New COVID-19 Vaccines Aim to Increase Global Access and Protect Against Emerging Variants

As COVID-19 continues to evolve, there is an urgent need for vaccines that are cheaper, easier to produce, and more effective against emerging variants of concern. This is especially important for low-income countries, which face challenges in accessing current vaccines. Peter Palese and his colleagues – Weina Sun, Adolfo García-Sastre and Florian Krammer – at the Icahn School of Medicine at Mount Sinai are developing innovative new COVID-19 vaccines based on the Newcastle disease virus – or ‘NDV’.